✦ LIBER ✦

A Phase I clinical trial of the combination of imatinib and paclitaxel in patients with advanced or metastatic solid tumors refractory to standard therapy

✍ Scribed by Michael J. Pishvaian, Rebecca Slack, Eunice Y. Koh…

Book ID: 120776532
Publisher: Springer
Year: 2012
Tongue: English
Weight: 356 KB
Volume: 70
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1969-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I trial of gemcitabine plus pacl

A phase I trial of gemcitabine plus paclitaxel combination therapy in patients with refractory solid tumors

✍ Sandler, A.; Raghavan, D.; Meropol, N.; Meyers, T.; Kindler, H.; Fox, S.; Perez, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Phase I Trial of Hedgehog Pathway Inhibi

Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors

✍ LoRusso, P. M.; Rudin, C. M.; Reddy, J. C.; Tibes, R.; Weiss, G. J.; Borad, M. J 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 89 KB

Phase I clinical trial of bortezomib in

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi

A phase I trial of sorafenib combined wi

A phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients

✍ Davies, Janine M.; Dhruva, Nirav S.; Walko, Christine M.; Socinski, Mark A.; Ber 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Phase I clinical and pharmacokinetic stu

Phase I clinical and pharmacokinetic study of ombrabulin (AVE8062) combined with cisplatin/docetaxel or carboplatin/paclitaxel in patients with advanced solid tumors

✍ Bahleda, Rastislav; Sessa, Cristiana; Del Conte, Gianluca; Gianni, Luca; Capri, 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 846 KB

A phase I trial of oral administration o

A phase I trial of oral administration of panobinostat in combination with paclitaxel and carboplatin in patients with solid tumors

✍ Suzanne F. Jones, Jeffrey R. Infante… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 167 KB